Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs
- 1 August 1987
- journal article
- research article
- Published by Elsevier in Regulatory Peptides
- Vol. 18 (3-4), 213-220
- https://doi.org/10.1016/0167-0115(87)90009-7
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis.JCI Insight, 1986
- Cholecystokinin AntagonistsHormone and Metabolic Research, 1986
- A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceusScience, 1985
- Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumideGastroenterology, 1985
- Effect of proglumide, a cholecystokinin receptor antagonist, on caerulein-stimulated pancreatic enzyme secretion and pancreatic polypeptide release in the dogRegulatory Peptides, 1984
- Release of Pancreatic and Gastric Somatostatin-Like Immunoreactivity in Response to the Octapeptide of Cholecystokinin, Secretin Gastric Inhibitory Polypeptide, and Gastrin-17 in Dogs*Endocrinology, 1980
- Gastrin-related peptides as stimulants of pancreatic and gastric secretionAmerican Journal of Physiology-Legacy Content, 1969